Investment Banking

At LifeSci Capital, our sole focus is our healthcare clients. Our seasoned team of investment banking professionals provides thoughtful, actionable advice related to corporate finance strategy and execution as well as mergers and acquisitions advisory.

Investment Banking Capabilities

The most effective advice does not exist in a vacuum. The close relationships that we develop with investors through our research and equity capital markets activities allow us to better understand investor sentiment and provide actionable advice. In addition, our deep experience in a broad range of M&A transaction types provides our clients with senior level attention and expertise.

Corporate Finance

Private Capital Advisory

Mergers & Acquisitions 

Equity & Debt Capital Markets

SPAC Financings

Our Banking Team

Bob Spivak

Associate

Chase Oswald

Analyst

Chris Nardo

Managing Director

David Dobkin

Managing Director

Elizabeth Morgan

Managing Director

Hany Awadalla

Head of Investment Banking, Managing Director

Matthew Margiotta

Associate

Patrick Charles

Associate

Robert Fromberg

Managing Director

Ryan Gaitan

Managing Director

Ryan Tierney

Associate

Stephanie Gajdjis

Analyst

Tom Rorke

Managing Director

Proven Success

Our transaction experience has grown through the trusted partnerships we have formed with our clients.

$B
Total Deal Value
Total Transactions

47
IPOs & Follow Ons

SPAC Transactions

Our Transactions

October 2022

Co-Manager

$ 75.0 Million

September 2022

Placement Agent

$ 176.6 Million

September 2022

Bookrunner

$ 150.0 Million

September 2022

IPO

Co-Manager

$ 213.1 Million

September 2022

Co-Manager

$ 80.5 Million

September 2022

Joint Bookrunner

€ 49.2 Million

We are a full service investment bank specializing in the life sciences and healthcare